SPOC Platform Development

About SPOC Biosciences

SPOC Biosciences is an early-stage biotech founded in 2020, pioneering a high-throughput proteomics platform that integrates on-chip protein synthesis with real-time biosensing. Its core technology, the SPOC Platform, is designed to produce and characterize thousands of proteins simultaneously, promising a 100x scale improvement and a 90% cost reduction over conventional recombinant protein workflows. The company is currently in a pre-revenue, platform development stage, offering early access to select customers to generate large-scale kinetic data critical for AI drug discovery and therapeutic optimization.

Therapeutic Areas